TipRanks
BioView Ltd. (IL:BIOV)
TASE:BIOV
Israel Market
BIOV
Bio View
RESEARCH TOOLSreports

Bio View (BIOV) Ratios

0 Followers

Bio View Ratios

IL:BIOV's free cash flow for Q2 2026 was ₪0.49. For the 2026 fiscal year, IL:BIOV's free cash flow was decreased by ₪ and operating cash flow was ₪-0.20. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.62 1.88 2.51 2.68 3.11
Quick Ratio
 1.09 1.17 1.65 2.15 2.59
Cash Ratio
 0.59 0.57 0.84 1.32 1.97
Solvency Ratio
 -0.96 -1.29 -0.14 0.15 0.15
Operating Cash Flow Ratio
 0.05 -0.36 -0.32 0.01 0.10
Short-Term Operating Cash Flow Coverage
 0.00 -2.36 -1.96 0.10 0.77
Net Current Asset Value
₪ 3.84M₪ 5.68M₪ 13.90M₪ 17.28M₪ 17.10M
Leverage Ratios
Debt-to-Assets Ratio
 0.11 0.14 0.06 0.08 0.10
Debt-to-Equity Ratio
 0.31 0.30 0.09 0.13 0.14
Debt-to-Capital Ratio
 0.24 0.23 0.08 0.11 0.13
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 2.76 2.11 1.47 1.54 1.48
Debt Service Coverage Ratio
 0.00 -8.74 -0.63 1.28 1.48
Interest Coverage Ratio
 0.00 -33.63 -7.71 1.86 3.79
Debt to Market Cap
 0.00 0.06 0.04 0.03 <0.01
Interest Debt Per Share
 15.26 22.30 0.17 0.03 0.31
Net Debt to EBITDA
 1.17 0.30 6.61 -4.16 -5.90
Profitability Margins
Gross Profit Margin
49.29%43.89%60.65%61.48%57.20%
EBIT Margin
-23.16%-45.30%-10.30%3.19%3.81%
EBITDA Margin
-14.81%-36.06%-3.68%8.42%8.94%
Operating Profit Margin
-23.34%-39.15%-11.21%2.20%3.95%
Pretax Profit Margin
-30.16%-45.90%-11.14%2.29%3.00%
Net Profit Margin
-63.32%-76.93%-12.27%1.10%2.01%
Continuous Operations Profit Margin
-63.32%-76.93%-12.27%1.10%2.01%
Net Income Per EBT
209.96%167.62%110.19%48.06%67.09%
EBT Per EBIT
129.20%117.22%99.34%104.05%76.02%
Return on Assets (ROA)
-70.78%-77.10%-9.36%0.91%1.40%
Return on Equity (ROE)
-162.52%-162.85%-13.72%1.40%2.08%
Return on Capital Employed (ROCE)
-54.54%-69.14%-12.08%2.55%3.59%
Return on Invested Capital (ROIC)
-48.26%-62.01%-10.66%1.11%2.23%
Return on Tangible Assets
-70.78%-77.10%-9.36%0.91%1.40%
Earnings Yield
-134.37%-67.69%-7.91%0.83%0.01%
Efficiency Ratios
Receivables Turnover
 10.23 7.74 5.28 4.69 5.51
Payables Turnover
 8.65 17.53 15.85 5.22 7.50
Inventory Turnover
 2.04 1.84 1.21 2.12 2.40
Fixed Asset Turnover
 8.29 6.13 10.25 8.43 5.69
Asset Turnover
 1.12 1.00 0.76 0.83 0.70
Working Capital Turnover Ratio
 3.46 1.79 1.47 1.70 1.41
Cash Conversion Cycle
 172.45 224.62 347.95 179.71 169.65
Days of Sales Outstanding
 35.67 47.18 69.16 77.77 66.19
Days of Inventory Outstanding
 178.99 198.27 301.83 171.88 152.14
Days of Payables Outstanding
 42.21 20.83 23.03 69.94 48.69
Operating Cycle
 214.66 245.44 370.99 249.66 218.33
Cash Flow Ratios
Operating Cash Flow Per Share
 3.76 -22.54 -0.22 <0.01 0.07
Free Cash Flow Per Share
 3.58 -22.93 -0.22 >-0.01 0.04
CapEx Per Share
 0.18 0.39 <0.01 <0.01 0.03
Free Cash Flow to Operating Cash Flow
 0.95 1.02 1.01 -0.79 0.53
Dividend Paid and CapEx Coverage Ratio
 20.72 -57.68 -88.74 0.56 2.12
Capital Expenditure Coverage Ratio
 20.72 -57.68 -88.74 0.56 2.12
Operating Cash Flow Coverage Ratio
 0.25 -1.09 -1.57 0.04 0.24
Operating Cash Flow to Sales Ratio
 0.03 -0.15 -0.12 <0.01 0.03
Free Cash Flow Yield
5.00%-13.73%-7.90%-0.26%<0.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.75 -1.52 -12.64 119.87 8.72K
Price-to-Sales (P/S) Ratio
 0.48 1.14 1.55 1.32 175.70
Price-to-Book (P/B) Ratio
 1.45 2.41 1.73 1.68 181.10
Price-to-Free Cash Flow (P/FCF) Ratio
 19.99 -7.28 -12.66 -379.43 10.02K
Price-to-Operating Cash Flow Ratio
 18.83 -7.41 -12.81 300.07 5.29K
Price-to-Earnings Growth (PEG) Ratio
 0.02 >-0.01 0.01 -1.27 -126.89
Enterprise Value Multiple
 -2.04 -2.86 -35.57 11.53 1.96K
Enterprise Value
 6.26M 20.52M 33.54M 33.73M 5.11B
EV to EBITDA
 -2.04 -2.86 -35.57 11.53 1.96K
EV to Sales
 0.30 1.03 1.31 0.97 175.18
EV to Free Cash Flow
 12.70 -6.60 -10.68 -278.74 9.99K
EV to Operating Cash Flow
 12.09 -6.71 -10.80 220.44 5.27K
Tangible Book Value Per Share
 48.81 69.42 1.64 0.20 2.03
Shareholders’ Equity Per Share
 48.81 69.42 1.64 0.20 2.03
Tax and Other Ratios
Effective Tax Rate
 -1.10 -0.68 -0.10 0.52 0.33
Revenue Per Share
 150.45 146.94 1.83 0.26 2.10
Net Income Per Share
 -95.27 -113.04 -0.22 <0.01 0.04
Tax Burden
 2.10 1.68 1.10 0.48 0.67
Interest Burden
 1.30 1.01 1.08 0.72 0.79
Research & Development to Revenue
 0.17 0.21 0.26 0.24 0.17
SG&A to Revenue
 0.57 0.62 0.16 0.22 0.11
Stock-Based Compensation to Revenue
 0.02 0.00 <0.01 <0.01 <0.01
Income Quality
 -0.04 0.20 1.09 0.19 1.11
Currency in ILS